Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNY)
NASDAQ:SNY
SNY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$45.22 - $58.97
Previous CloseN/A
Volume824.98K
Average Volume (3M)2.54M
Market Cap
$132.02B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.8
Beta0.45
Next Earnings
Jan 30, 2025EPS Estimate
0.74Last Dividend Ex-Date
May 09, 2024Dividend Yield2.77%
Share Statistics
EPS (TTM)1.82
Shares Outstanding2,526,245,400
10 Day Avg. Volume2,629,012
30 Day Avg. Volume2,541,390
Standard Deviation0.06
R-Squared0.23
Alpha-0.00208
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$64.67Price Target Upside21.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
---
Bulls Say, Bears Say
Bulls Say
Product PipelineSanofi holds a diverse pipeline and is expected to launch or expand indications for over 10 drugs in FY25.
Revenue GrowthDupixent indication expansion will continue to drive revenues moving forward.
Bears Say
Competition RiskThere is a risk of Dupixent’s market share being diminished due to competition from alternatives such as JAK inhibitors.
Earnings PerformanceBoth 3Q23 revenue and earnings missed expectations.
Regulatory ChallengesAn initial U.S. filing for CSU received a CRL from FDA requesting additional efficacy data.
---
Ownership Overview
―
Insiders
3.87% Mutual Funds
0.04% Other Institutional Investors
95.88% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNY FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was $45.22 and its highest was $58.97 in the past 12 months.
What is Sanofi’s market cap?
Sanofi’s market cap is $132.02B.
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jan 30, 2025 which is 12 days ago.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Jan 30, 2025. The company reported $0.683 earnings per share for the quarter, missing the consensus estimate of $0.703 by -$0.02.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $1.478 which represents an annual dividend yield of 2.77%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is 0.74.
How many shares outstanding does Sanofi have?
Sanofi has 2,526,245,400 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $0.683 in its last earnings report, missing expectations of $0.703. Following the earnings report the stock price went up 3.835%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in SNY
---
Sanofi Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$64.67 (21.22% Upside)
$64.67 (21.22% Upside)
Blogger Sentiment
Bullish
SNY Sentiment 92%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 594.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.38%
12-Months-Change
Fundamentals
Return on Equity
7.29%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Sanofi
Founded in 1973, Sanofi is a France-based leading global healthcare company, which provides therapeutic solutions worldwide. It operates through business units including Pharmaceuticals (comprised of General Medicines and Speciality Care), Consumer Healthcare, and Vaccines.
---
SNY Company Deck
---
SNY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance in sales and strategic growth, especially in new product launches and the vaccines segment. However, there are concerns about increased expenses, slight gross margin decline, and impacts from healthcare policy changes. Despite these challenges, the company's growth outlook and pipeline advancements contribute to a generally positive sentiment.Read More>---
SNY Stock 12 Month Forecast
Average Price Target
$64.67
▲(21.22% Upside)
Technical Analysis
Best Analysts Covering SNY
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+3.59%
reiterated a buy rating 2 months ago
Copying Luisa Hector's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +3.59% per trade.
---